Further, PLA2G2A polymorphisms have been linked to an increased risk of developing MetS and T2DM [60]; thus, it may be prudent for further investigation to corroborate a lack of correlation between PLA2G2A and MetS-OA, especially in early disease sufferers. Here, PLA2G2A is linked to metabolic syndrome.